Published rather than Proposed Definitions for Invasive Fungal Infection Must Be Applied to Allow Standardization in Clinical Trials

June 2004
Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1648
Academic Journal
The European Organization for Research and Treatment of Cancer Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) created a task force to examine the definitions for invasive fungal infection (IFI) used in the medical literature. This task force identified considerable inconsistency in defining IFI in patients with cancer and in recipients of haematopoietic stem cell transplants (SCTs) and highlighted a need for standard definitions for use in clinical and epidemiological research.


Related Articles

  • Therapeutic Outcome and Prognostic Factors of Invasive Aspergillosis in an Infectious Disease Department: A Review of 34 Cases. Gallien, S.; Fournier, S.; Porcher, R.; Bottero, J.; Ribaud, P.; Sulahian, A.; Socié, G.; Molina, J.-M. // Infection;Dec2008, Vol. 36 Issue 6, p533 

    Invasive aspergillosis (IA) is one of the most frequent, feared and life-threatening opportunistic infection in immunocompromised patients. We wished to assess the therapeutic outcome and identify prognostic factors of IA. We reviewed retrospectively all patients managed in our department for a...

  • Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry. Neofytos, D.; Horn, D.; Anaissie, E.; Steinbach, W.; Olyaei, A.; Fishman, J.; Pfaller, M.; Chang, C.; Webster, K.; Marr, K. // Clinical Infectious Diseases;2/1/2009, Vol. 48 Issue 3, p265 

    Background. With use of data from the Prospective Antifungal Therapy (PATH) Alliance registry, we performed this multicenter, prospective, observational study to assess the epidemiologic characters and outcomes of invasive fungal infection (IFI) in hematopoietic stem cell transplant (HSCT)...

  • High Mortality in Invasive Aspergillosis: What We Need to Know for Determination of Poor Prognosis and Next Countermeasures. Kohno, Shigeru // Clinical Infectious Diseases;11/1/2008, Vol. 47 Issue 9, p1185 

    The article discusses the definitions and guidelines regarding the invasive aspergillosis (IA). It states that the changes mean that there has been an evolution in the techniques used for the precise and rapid diagnosis of IA. It identifies the prognostic factors linked with overall and...

  • 24. Infections (bacterial / fungal).  // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS240 

    Bone Marrow Transplantation (2001) 29, Suppl. 2, S240–S249. DOI: 10.1038/sj/bmt/1703493

  • Users' guide to the surgical literature. Mihailovic, Alexandra; Bell, Chaim M.; Urbach, David R. // Canadian Journal of Surgery;Apr2005, Vol. 48 Issue 2, p148 

    Introduction: Some articles in surgical journals identify themselves as case-control studies, but their methods differ substantially from conventional epidemiologic case-control study (EGG) designs. Most of these studies appear instead to be retrospective cohort studies or comparisons of case...

  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Kontoyiannis, Dimitrios P.; Marr, Kieren A.; Park, Benjamin J.; Alexander, Barbara D.; Anaissie, Elias J.; Walsh, Thomas J.; Ito, James; Andes, David R.; Baddley, John W.; Brown, Janice M.; Brumble, Lisa M.; Freifeld, Alison G.; Hadley, Susan; Herwaldt, Loreen A.; Kauffman, Carol A.; Knapp, Katherine; Lyon, G. Marshall; Morrison, Vicki A.; Papanicolaou, Genovefa; Patterson, Thomas F. // Clinical Infectious Diseases;4/15/2010, Vol. 50 Issue 8, p1091 

    Background. The incidence and epidemiology of invasive fungal infections (IFIs), a leading cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived mainly from single-institution retrospective studies. Methods. The Transplant Associated Infections Surveillance...

  • Passenger Lymphocyte Syndrome and Liver Transplantation. Audet, Maxime; Panaro, Fabrizio; Piardi, Tullio; Ping Huang; Cag, Murat; Cinqualbre, Jacques; Wolf, Philippe // Clinical & Developmental Immunology;2008, p1 

    The authors reviewed the passenger lymphocyte syndrome (PLS) that has appeared after transplantation. The definition, mechanism, serological, clinical features, and treatment for PLS after solid organ transplantation, especially liver transplantation, are described. The PLS refers to the...

  • The activity of hematopoietic stem cell transplantation in Korea. Lee, J. W.; Kim, C. C. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS92 

    Since the first successful allogeneic hematopoietic SCT (HSCT) was performed in Korea in 1983, there has been a noticeable progress in both the quantity and quality of HSCT over 24 years. There are 38 HSCT centers in Korea and the number of both allogeneic and autologous HSCTs has been...

  • As one journal ends open-access policy, a new one embraces it. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;9/30/2003, Vol. 169 Issue 7, p700 

    Announces that the Public Library of Science (PLoS), a nonprofit organization committed to making the world's scientific and medical literature a free public resource, is launching the journals "PLoS Biology," on October 13, 2003 and "PloS Medicine" in 2004. Amount researchers' funding...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics